Close

content

ILIAS Biologics Granted Key Patent for Exosome-based Drug Delivery System in the United States

ILIAS Biologics Inc., a global leader in exosome-based therapeutics, announced that the Company has been granted a key exosome engineering patent by the United...

GSK and Medicago announce collaboration to develop a novel adjuvanted COVID-19 candidate vaccine

GSK and Medicago announced a collaboration to develop and evaluate a COVID-19 candidate vaccine combining Medicago’s recombinant Coronavirus Virus-Like Particles (CoVLP) with GSK’s pandemic...

Novartis Gets European Commission Approval For Enerzair Breezhaler Asthma Treatment

Novartis announced that the EC has approved Enerzair Breezhaler as a maintenance treatment of asthma in adult patients not adequately controlled with a maintenance...

Antares Vision Expands AI-Based Data Monitoring Software Portfolio

Antares Vision, global leader in visual inspection systems, track & trace solutions, and smart data management, has expanded its portfolio of AI-based production facility...

Regeneron Announces Manufacturing and Supply Agreement for BARDA for REGN-COV2 Anti-Viral Antibody Cocktail

Regeneron Pharmaceuticals, Inc. announced that, as part of Operation Warp Speed, the Biomedical Advanced Research and Development Authority (BARDA), part of the Office of...

ADMA Biologics Opens Its Newest ADMA BioCenters Plasma Collection Facility

ADMA Biologics, Inc., an end-to-end commercial biopharmaceutical company dedicated to manufacturing, marketing and developing specialty plasma-derived biologics, announced the commencement of operations and initiation...

AGC Biologics Expands Development Capacities for pDNA Services at Heidelberg Site

Committed to continuous innovation and expansion of its service offerings, AGC Biologics has announced the expansion of its pDNA Center of Excellence in Heidelberg,...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read